![A 56-year-old woman with metastatic high-grade neuroendocrine small cell carcinoma of a left paratracheal lymph node underwent radiotherapy. The 1.5-cm metastatic hypermetabolic left paratracheal lymph node on pretherapy FDG PET/CT showed intense FDG uptake (SUVmax 5.9, arrows; **A**: maximum intensity projection \[MIP\] PET; **B**--**E**: transaxial PET, CT soft tissue window, CT lung window, and fused PET/CT images). Of note, there were no ground-glass opacities (GGOs) in bilateral lungs.](rlu-publish-ahead-of-print-10.1097.rlu.0000000000003137-g001){#FU1}

![Approximately 16 days prior to the restaging PET/CT, the patient had close contact with a COVID-19--positive patient. As she was asymptomatic and afebrile, the local authority advised her to self-quarantine for 14 days, and no COVID-19 test was performed. After 14 days' self-quarantine, the patient presented for prescheduled restaging FDG PET/CT. Upon arrival, she had low-grade fever of 37.1°C, oxygen saturation of 93% at room air, and no shortness of breath or cough. Infectious disease service confirmed that the patient did not meet criteria for COVID-19 testing, and it was ok to proceed with PET/CT. Given her contact history of COVID-19, the patient was instructed to wear mask and kept in an isolated waiting room, while PET/CT was interpreted immediately. The FDG PET/CT images (**A**: MIP PET; **B**--**E**: transaxial PET, CT soft tissue window, CT lung window, and fused PET/CT; **F**--**H**: transaxial PET, CT lung window, and fused PET/CT images; and **I**--**K**: coronal PET, CT lung window, and fused PET/CT) showed that the metastatic left paratracheal lymph node has improved, now subcentimeter in size and with only background FDG uptake (long arrows in **B**, **C**), suggestive of favorable treatment response. However, there are new bilateral multifocal hypermetabolic GGOs (short arrows in **A**--**K**, SUVmax up to 4.8) compared with PET/CT 10 weeks ago (Fig. 1), suggestive of an infectious etiology. The GGOs presented as a "crazy paving" pattern, as reported in COVID-19 pneumonia.^[@bib1]--[@bib4]^ At rechecking of vital signs, the patient complained of sore throat and shortness of breath with exertion, oxygen saturation was 97% at room air, but temperature rises to 37.7°C. Subsequently, the patient was admitted for further management. The COVID-19 test result was confirmed as positive the next day. The patient received treatment with nasal oxygen, azithromycin, and hydroxychloroquine. There are only a handful cases that have been reported of FDG PET/CT in patients with COVID-19.^[@bib5]--[@bib7]^ However, nuclear medicine physicians should be aware of the suspicious COVID-19 image findings during the COVID-19 pandemic time and be vigilant of the incidental findings suggestive of an active infection/inflammation process,^[@bib8]^ especially in patients with known contact history and with subtle symptoms or even asymptomatic.^[@bib5]^ The hypermetabolic activity of GGOs is suggestive of active infection, as in this patient. We are pondering the extent and intensity of hypermetabolic GGOs on PET/CT might have correlation with COVID-19 clinical presentation and severity, but this will need more data to verify, and its anatomic correlation with the CT appearance during the disease course^[@bib9]^ remains to be seen.](rlu-publish-ahead-of-print-10.1097.rlu.0000000000003137-g002){#FU2}
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